1-2 of 2
Fengtian He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells

Xinzhe Li, Bo Li, Zhenhong Ni, Peng Zhou, Bin Wang, Jintao He, Haojun Xiong, Fan Yang, Yaran Wu, Xilin Lyu, Yan Zhang, Yijun Zeng, Jiqin Lian, Fengtian He
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (9): 1806–1818.
https://doi.org/10.1158/1535-7163.MCT-16-0763
Published: 04 September 2017
View article titled, Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells
Open the PDF for Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation

Jiqin Lian, Zhenhong Ni, Xufang Dai, Chang Su, Amber Rae Smith, Liang Xu, Fengtian He
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 416–426.
https://doi.org/10.1158/1535-7163.MCT-11-0559
Published: 08 February 2012
View article titled, Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation
Open the PDF for Sorafenib Sensitizes (−)-Gossypol-Induced Growth Suppression in Androgen-Independent Prostate Cancer Cells via Mcl-1 Inhibition and Bak Activation in another window
Includes: Supplementary data